96 related articles for article (PubMed ID: 8444401)
1. [Arteriosclerosis obliterans that was improved by LDL apheresis].
Suzuki H; Mutoh E; Kitagawa T; Kubota H; Takasugi Y
Hokkaido Igaku Zasshi; 1993 Jan; 68(1):126-31. PubMed ID: 8444401
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
4. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: two cases with marked alleviation of clinical symptoms.
Suzuki T; Sato Y; Niizuma S; Kushiro T; Tani S; Ishikawa K; Kajiwara N; Kanmatsuse K; Ikeda H; Takahashi M; Kojima S
J Clin Apher; 2007; 22(5):287-91. PubMed ID: 17610290
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Ushiyama C; Osada S; Inoue T; Shimada N; Koide H
J Diabetes Complications; 2003; 17(6):349-54. PubMed ID: 14583180
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
10. [Clinical long-term results of H.E.L.P.-apheresis].
Schuff-Werner P
Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
[TBL] [Abstract][Full Text] [Related]
11. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
12. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
[TBL] [Abstract][Full Text] [Related]
13. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
Otto C; Berster J; Otto B; Parhofer KG
J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
[TBL] [Abstract][Full Text] [Related]
14. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
15. Treatment of arteriosclerotic obstruction by LDL adsorption.
Agishi T; Naganuma S; Nakasato S; Kitajima K; Ota K; Ban K; Nomura M
Angiology; 1993 Mar; 44(3):222-7. PubMed ID: 8442532
[TBL] [Abstract][Full Text] [Related]
16. [Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis].
Bláha V; Zadák Z; Bláha M; Havel E; Solichová D; Brátová M; Malý J; Kmonícek L
Cas Lek Cesk; 1998 Jul; 137(14):424-9. PubMed ID: 9748737
[TBL] [Abstract][Full Text] [Related]
17. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: change in prostacyclin and effect on ischemic symptoms.
Mii S; Mori A; Sakata H; Nakayama M; Tsuruta H
Angiology; 1998 Mar; 49(3):175-80. PubMed ID: 9523539
[TBL] [Abstract][Full Text] [Related]
18. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
Igarashi K; Tsuji M; Nishimura M; Horimoto M
J Clin Apher; 2004; 19(1):11-6. PubMed ID: 15095396
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis obliterans of the lower extremities in Thai patients.
Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K
J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients.
Baldassarre D; Busnach G; Amato M; Pazzucconi F; Sirtori CR
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):108-17. PubMed ID: 10464783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
